[
    {
        "data": {
            "public_metrics": {
                "retweet_count": 0,
                "reply_count": 0,
                "like_count": 0,
                "quote_count": 0
            },
            "referenced_tweets": [
                {
                    "type": "replied_to",
                    "id": "1396525113734926338"
                }
            ],
            "entities": {
                "mentions": [
                    {
                        "start": 80,
                        "end": 95,
                        "username": "SerumInstIndia",
                        "id": "925599812510138368"
                    },
                    {
                        "start": 217,
                        "end": 221,
                        "username": "WHO",
                        "id": "14499829"
                    }
                ],
                "hashtags": [
                    {
                        "start": 96,
                        "end": 107,
                        "tag": "Covishield"
                    }
                ],
                "annotations": [
                    {
                        "start": 145,
                        "end": 151,
                        "probability": 0.2566,
                        "type": "Person",
                        "normalized_text": "Covaxin"
                    },
                    {
                        "start": 191,
                        "end": 197,
                        "probability": 0.3474,
                        "type": "Person",
                        "normalized_text": "Covaxin"
                    }
                ]
            },
            "created_at": "2021-05-23T18:03:26.000Z",
            "text": "Multiple reports said that over 130 countries across the globe currently accept @SerumInstIndia #Covishield vaccine to enter their country while Covaxin is accepted in only nine nations Also,Covaxin is not yet on the @WHO Emergency Use Listing (EUL).",
            "lang": "en",
            "in_reply_to_user_id": "794647707050770432",
            "id": "1396527206264836096",
            "author_id": "794647707050770432",
            "reply_settings": "everyone",
            "geo": {
                "place_id": "5c0761bdffa0cb64"
            },
            "source": "Twitter for iPhone",
            "conversation_id": "1396525113734926338",
            "possibly_sensitive": false,
            "context_annotations": [
                {
                    "domain": {
                        "id": "123",
                        "name": "Ongoing News Story",
                        "description": "Ongoing News Stories like 'Brexit'"
                    },
                    "entity": {
                        "id": "1220701888179359745",
                        "name": "COVID-19"
                    }
                }
            ]
        },
        "id": 1396527206264836096,
        "text": "Multiple reports said that over 130 countries across the globe currently accept @SerumInstIndia #Covishield vaccine to enter their country while Covaxin is accepted in only nine nations Also,Covaxin is not yet on the @WHO Emergency Use Listing (EUL).",
        "attachments": null,
        "author_id": 794647707050770432,
        "context_annotations": [
            {
                "domain": {
                    "id": "123",
                    "name": "Ongoing News Story",
                    "description": "Ongoing News Stories like 'Brexit'"
                },
                "entity": {
                    "id": "1220701888179359745",
                    "name": "COVID-19"
                }
            }
        ],
        "conversation_id": 1396525113734926338,
        "created_at": "2021-05-23T18:03:26+00:00",
        "entities": {
            "mentions": [
                {
                    "start": 80,
                    "end": 95,
                    "username": "SerumInstIndia",
                    "id": "925599812510138368"
                },
                {
                    "start": 217,
                    "end": 221,
                    "username": "WHO",
                    "id": "14499829"
                }
            ],
            "hashtags": [
                {
                    "start": 96,
                    "end": 107,
                    "tag": "Covishield"
                }
            ],
            "annotations": [
                {
                    "start": 145,
                    "end": 151,
                    "probability": 0.2566,
                    "type": "Person",
                    "normalized_text": "Covaxin"
                },
                {
                    "start": 191,
                    "end": 197,
                    "probability": 0.3474,
                    "type": "Person",
                    "normalized_text": "Covaxin"
                }
            ]
        },
        "geo": {
            "place_id": "5c0761bdffa0cb64"
        },
        "in_reply_to_user_id": 794647707050770432,
        "lang": "en",
        "non_public_metrics": null,
        "organic_metrics": null,
        "possibly_sensitive": false,
        "promoted_metrics": null,
        "public_metrics": {
            "retweet_count": 0,
            "reply_count": 0,
            "like_count": 0,
            "quote_count": 0
        },
        "referenced_tweets": [
            {
                "data": {
                    "type": "replied_to",
                    "id": "1396525113734926338"
                },
                "id": 1396525113734926338,
                "type": "replied_to"
            }
        ],
        "reply_settings": "everyone",
        "source": "Twitter for iPhone",
        "withheld": null
    }
]